These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29076185)

  • 21. Exact confidence bounds following adaptive group sequential tests.
    Brannath W; Mehta CR; Posch M
    Biometrics; 2009 Jun; 65(2):539-46. PubMed ID: 18759843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adaptive designs with correlated test statistics.
    Götte H; Hommel G; Faldum A
    Stat Med; 2009 May; 28(10):1429-44. PubMed ID: 19226563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated confidence intervals for adaptive group sequential trials.
    Mehta CR; Bauer P; Posch M; Brannath W
    Stat Med; 2007 Dec; 26(30):5422-33. PubMed ID: 17918195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Confidence intervals for the between-study variance in random-effects meta-analysis using generalised heterogeneity statistics: should we use unequal tails?
    Jackson D; Bowden J
    BMC Med Res Methodol; 2016 Sep; 16(1):118. PubMed ID: 27604952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On sample size and inference for two-stage adaptive designs.
    Liu Q; Chi GY
    Biometrics; 2001 Mar; 57(1):172-7. PubMed ID: 11252594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sample sizes for batch acceptance from single- and multistage designs using two-sided normal tolerance intervals with specified content.
    Hauck WW; Shaikh R
    J Biopharm Stat; 2001 Nov; 11(4):335-46. PubMed ID: 12018783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Introduction of a User-oriented Application for Biometrical Sample Size Calculation in Clinical and Epidemiological Trials].
    Geis B; Tulka S; Knippschild S; Krummenauer F
    Klin Monbl Augenheilkd; 2021 Feb; 238(2):179-185. PubMed ID: 31117147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal adaptive two-stage designs for phase II cancer clinical trials.
    Englert S; Kieser M
    Biom J; 2013 Nov; 55(6):955-68. PubMed ID: 23868324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inference for Surrogate Endpoint Validation in the Binary Case.
    Bebu I; Mathew T; Agan B
    J Biopharm Stat; 2015; 25(6):1272-84. PubMed ID: 25616958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accurate confidence intervals for proportion in studies with clustered binary outcome.
    Shan G
    Stat Methods Med Res; 2020 Oct; 29(10):3006-3018. PubMed ID: 32242483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Confidence intervals for the difference between independent binomial proportions: comparison using a graphical approach and moving averages.
    Laud PJ; Dane A
    Pharm Stat; 2014; 13(5):294-308. PubMed ID: 25163425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exact inference for adaptive group sequential designs.
    Gao P; Liu L; Mehta C
    Stat Med; 2013 Oct; 32(23):3991-4005. PubMed ID: 23686358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous confidence intervals for a success probability and intraclass correlation, with an application to screening mammography.
    Kim J; Lee JH
    Biom J; 2013 Nov; 55(6):944-54. PubMed ID: 24115052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival endpoints and adaptive designs.
    Bauer P
    Biom J; 2006 Aug; 48(4):730-1. PubMed ID: 16972725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential equivalence testing and repeated confidence intervals, with applications to normal and binary responses.
    Jennison C; Turnbull BW
    Biometrics; 1993 Mar; 49(1):31-43. PubMed ID: 8513110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypothesis testing for two-stage designs with over or under enrollment.
    Zeng D; Gao F; Hu K; Jia C; Ibrahim JG
    Stat Med; 2015 Jul; 34(16):2417-26. PubMed ID: 25809924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small-sample confidence limits for parameters under inequality constraints with application to quantal bioassay.
    Morris MD
    Biometrics; 1988 Dec; 44(4):1083-92. PubMed ID: 3233247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Confidence intervals based on some weighting functions for the difference of two binomial proportions.
    Maruo K; Kawai N
    Stat Med; 2014 Jun; 33(13):2288-96. PubMed ID: 24644149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exact confidence intervals following a group sequential test.
    Tsiatis AA; Rosner GL; Mehta CR
    Biometrics; 1984 Sep; 40(3):797-803. PubMed ID: 6518248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Point and interval estimation of primary and secondary parameters in a two-stage adaptive clinical trial.
    Liu A; Wu C; Yu KF
    J Biopharm Stat; 2008; 18(2):211-26. PubMed ID: 18327717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.